FdaApplication
ANDA 211204
Identifiers
- fda_app_no: ANDA211204
Properties
| Property | Value |
|---|---|
| applicant_name | AMNEAL PHARMACEUTICALS OF NEW YORK LLC |
| application_type | ANDA |
| approval_date | 2019-11-01 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ERYTHROMYCIN ETHYLSUCCINATE | ERYTHROMYCIN ETHYLSUCCINATE | EQ 200MG BASE/5ML | GRANULE;ORAL |
| ERYTHROMYCIN ETHYLSUCCINATE | ERYTHROMYCIN ETHYLSUCCINATE | EQ 400MG BASE/5ML | GRANULE;ORAL |
2 products